Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.Clinical Pharmacology and Therapeutics|August 10, 2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor DosingJohn J Lima, Cameron D Thomas, Julia Barbarino, et al.Clinical Pharmacology and Therapeutics|July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker TherapyJulio D Duarte, Cameron D Thomas, Craig R Lee, et al.Journal of the American Heart Association|June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary InterventionKayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.Clinical Pharmacology and Therapeutics|October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary InterventionLarisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.Clinical and Translational Science|August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategiesLarisa H Cavallari, Craig R Lee, Francesco Franchi, et al.Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.Journal of the American Heart Association|February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.Pageof 3